Funding for this research was provided by:
Fund from Guangzhou Institute of Pediatrics, Guangzhou Women and Children's Medical Center (YIP-2019-031)
Research Start-up Fund for Guangdong Second Provincial General Hospital Introduced Talent (YY2018-006)
Article History
Received: 2 December 2019
Revised: 28 February 2020
Accepted: 9 March 2020
First Online: 8 April 2020
Compliance with ethical standards
:
: ZXF and DLC declare no conflict of interest. JXQ declares that the four <i>vhh</i> sequences encoding anti-GFP nanobodies described in this paper have been applied for a patent in China.
: All applicable international, national, and/or institutional guidelines for the care and use of animals were followed.